Thermo Fisher opens biologics manufacturing site in Switzerland

October 11, 2021

Thermo Fisher Scientific (NYSE:TMO) has assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland as part of its strategic partnership with CSL Limited announced last year.

The Lengnau site will become part of TMO's global biologics manufacturing network, and approx. 200 employees will join. The site is a 1.5M square-foot facility that will leverage highly flexible bioproduction technologies, including both single-use and stainless steel with up to 12,500L bioreactor capacity.

"Through our partnership with CSL, this site further strengthens our unique customer value proposition to leverage our scale and depth of capabilities for pharma and biotech customers," said Michel Lagarde, executive vice president of Thermo Fisher Scientific .

Following completion of site construction in 2022, TMO will initially support manufacturing of CSL's next-generation recombinant factor IX product Idelvion for patients with hemophilia B. Over time, Thermo Fisher plans to expand the use of the site to include additional biopharma customers.

Over the current book year the total revenue from the company in Waltham will be 36.05 billion USD (consensus estimates). This is hugely more than 2021's revenue of 32.22 billion USD.

Historical revenues and results Thermo Fisher Scientific plus estimates 2021

The analysts expect for 2021 a net profit of 8.77 billion USD. The majority of the analysts expects for this year a profit per share of 22.17 USD. With this the price/earnings-ratio is 26.34.

Per share the analysts anticipate on a dividend of 97 cents per share. Thus the dividend yield equals 0.17 percent. The average dividend yield of the health care companies equals a low 1.27 percent.

Based on the current number of outstanding shares Thermo Fisher Scientific 's market capitalization is 232.83 billion USD. 26

On Friday, the stock closed at 583.92 USD.

Historical stock prices Thermo Fisher Scientific

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

Other stock news

Thermo Fisher bid to acquire PPD comes under regulatory scrutiny in U.K.

Thermo Fisher to spend $17 billion on PPD acquisition

Analysts expect over 2020 rising revenue Thermo Fisher Scientific

Sector news

Analysts expect over 2023 revenue decrease Basic-Fit

Analysts: less sales Stericycle

Ibersol now in top highest dividend yields in Portugal

Analysts foresee record year for Agilent Technologies

WeWork to buy Common Desk, boosting presence in Texas, North Carolina

SoftBank seeks to sell $550M of WeWork rescue debt

National news

Analysts expect record sales Lockheed Martin

Analysts: more sales Halliburton

Fiserv's sales on record level according analysts' estimates

Intuitive Surgical's sales on record level according analysts' estimates

Analysts are counting on record year NetFlix

Analysts expect record sales CSX

Analysts expect sales decline Carmax

Press news

Quarterly statement three months 2024

HAMBORNER REIT AG starts 2024 with further growth in revenue and earnings

Aramco, top F1 team kindle racing enthusiasm among middle school students in Shanghai

Earth Day 2024: Coherent Corp. Announces Milestones in its Sustainability Journey

EfTEN United Property Fund distributes approximately 260 000 euros to investors

Pico Launches Machine Learning and AI Capabilities in Corvil Analytics 10.0 Software Release

Wearable Computing Market to cross $281.5 Bn by 2032, Says Global Market Insights Inc.

About us	Network	Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos	Analist.nlLinksISIN Glossary	MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x